≥99% HPLCPre-filled pen

Cardiogen

Name: Cardiogen
Brand: Dripfy
Availability: InStock

What it is?

Cardiogen is a peptide bioregulator positioned to support cardiac tissue function and cardiovascular resilience. It is studied for its potential role in promoting stable cardiac metabolism and tissue maintenance through organ-focused regulation.

Dripfy Advantage

Cardiac tissue targeting: Designed around heart-tissue support, aligning with organ-specific bioregulator concepts.
Protein synthesis regulation: Positioned to regulate protein synthesis in cardiac cells, supporting tissue integrity and maintenance markers.
Metabolic normalisation support: Associated with signalling that supports cardiac metabolism optimisation and functional stability endpoints.
Microcirculation and resilience interface: Often framed within protocols where circulation-related and endurance-support endpoints are tracked.

Clinical Applications & Therapeutic Potential

Cardiovascular function markers: Potential support for normal cardiac function endpoints and cardiovascular stability parameters.
Resilience and endurance frameworks: Positioned for cardiovascular resilience endpoints, particularly under metabolic or training stress loads.
Tissue maintenance dynamics: Potential contribution to long-term heart tissue maintenance and functional preservation markers.
Healthy ageing support: Relevant to longevity stacks where cardiovascular integrity is a core healthspan determinant.

Composition & Formulation

Class: Heart-specific bioregulatory peptide (cardiac bioregulator class)
Format: Ready-to-use pre-filled pen

€499

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

Cardiogen

Investigational cardiac-directed peptide bioregulator (Khavinson-type) · Pre-filled pen

D· Preliminary evidence

Cardiogen is a short peptide bioregulator from the Khavinson family, proposed to act on cardiac-tissue cells by influencing protein-synthesis and gene-regulatory signalling. The studied concept is that organ-directed peptides might help maintain stable cardiac cell metabolism and tissue integrity, but the evidence is predominantly preclinical. It has not been shown to prevent or treat cardiovascular disease in humans.

Studied use areas

Cardiac-tissue maintenance signalling (research interest)
Protein-synthesis regulation in heart cells
Cardiac cell metabolism stability (investigational)
Age-related cardiovascular resilience (exploratory framework)

Safety & status

Investigational bioregulator with no established human cardiovascular safety data; physician supervision required
Not approved as a medicine by EMA or MHRA
Cardiac symptoms are potentially serious and need urgent medical assessment, not peptide self-management

⚕ Clinical note: This is educational information only and not medical advice. Cardiogen is investigational; any use should be individualised and determined by a treating physician under appropriate supervision.

Evidence: Grade D — investigational; predominantly preclinical data, with no robust human clinical trials. · References: Peer-reviewed peptide-bioregulator (Khavinson) research literature; General cardiovascular physiology reviews; EMA/MHRA guidance on unlicensed investigational substances